Benzinga - Mon, 25 Jan 2021 17:25:46 -0400
Benzinga - Fri, 15 Jan 2021 13:36:59 -0400
Benzinga - Fri, 15 Jan 2021 08:32:12 -0400
Benzinga - Fri, 15 Jan 2021 05:59:44 -0400
Benzinga - Mon, 11 Jan 2021 18:06:31 -0400
Benzinga - Tue, 05 Jan 2021 11:11:08 -0400
Benzinga - Tue, 05 Jan 2021 09:38:54 -0400
Benzinga - Tue, 05 Jan 2021 09:26:00 -0400
Benzinga - Tue, 05 Jan 2021 07:20:23 -0400
Benzinga - Tue, 05 Jan 2021 05:40:22 -0400
Benzinga - Tue, 05 Jan 2021 05:29:30 -0400
Benzinga - Mon, 04 Jan 2021 15:30:26 -0400
Benzinga - Mon, 04 Jan 2021 13:50:07 -0400
Benzinga - Mon, 04 Jan 2021 13:21:14 -0400
Benzinga - Mon, 04 Jan 2021 11:21:39 -0400
load more
Sector: Health Care.Industry: Biotechnology
Calithera Biosciences Inc is a clinical-stage pharmaceutical company. The business activity of the firm is functioned through the region of US. It focuses on discovering and developing small molecule drugs directed against tumor and immune cell targets that control key metabolic pathways in the tumor microenvironment. Its lead product candidate is CB-839, an inhibitor of glutaminase for the treatment of solid tumors. Its other product candidate, CB-1158, is being developed for hematology and oncology indications.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-06
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-15
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CALACalithera Biosciences-0.69%203.2M

Calithera Biosciences Company Questions & Answers

Q

How do I buy Calithera Biosciences (CALA) stock?

A

You can purchase shares of Calithera Biosciences (NASDAQ: CALA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Calithera Biosciences's (CALA) main competitors?

A

Other companies in Calithera Biosciences’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Atossa Therapeutics (NASDAQ:ATOS) and Concert Pharmaceuticals (NASDAQ:CNCE).

Q

What is the target price for Calithera Biosciences?

A

The latest price target for Calithera Biosciences (NASDAQ: CALA) was reported by HC Wainwright & Co. on 2021-01-05. The analyst firm set a price target for 4.00 expecting CALA to rise to within 12 months (a possible 38.89% upside). 6 analyst firms have reported ratings in the last year.

Q

How much is Calithera Biosciences (CALA) stock ?

A

The stock price for Calithera Biosciences (NASDAQ: CALA) is $2.88 last updated Tue Mar 02 2021 21:00:03 GMT+0000 (Coordinated Universal Time).

Q

When is the next Calithera Biosciences (CALA) dividend?

A

There are no upcoming dividends for Calithera Biosciences.

Q

When is Calithera Biosciences (NASDAQ:CALA) reporting earnings?

A
Calithera Biosciences’s Q1 earnings are confirmed after-market from now on May 6, 2021.
Q

When is the upcoming split for CALA?

A

There is no upcoming split for Calithera Biosciences.